Abortion Pill Case Spurs Debate Ahead of Supreme Court Arguments

Reproductive health groups and conservative analysts are weighing in on the FDA’s regulation of the abortion pill mifepristone just days away from oral arguments in a case that will bring the abortion issue back to the Supreme Court for the first time since justices overturned Roe v. Wade.

Attorneys on behalf of the Food and Drug Administration and mifepristone brand-name manufacturer Danco Laboratories will appear before the high court on Tuesday, along with anti-abortion physicians represented by the Christian legal group Alliance Defending Freedom, who argue the FDA unlawfully removed safety restrictions on mifepristone.

The FDA and Danco had appealed ...